# Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal

> **NCT00661674** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Substance-Related Disorders

## Interventions

- **DRUG:** Palonosetron
- **DRUG:** Hydroxyzine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00661674
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661674, "Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00661674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*